Reports Q3 revenue $20,000 vs. $50,000 last year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VCNX:
- Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update
- Vaccinex reports clinical benefit in interim analyses from Phase 2 studies
- Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative Diseases
- Vaccinex announces presentation of findings for pepinemab
- Fly Insider; STAAR Surgical, Blade Air among week’s notable insider trades